An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma

Splenic marginal zone lymphoma (SMZL) is an indolent B-cell lymphoproliferative disorder characterised by 7q32 deletion, but the target genes of this deletion remain unknown. In order to elucidate the genetic target of this deletion, we performed an integrative analysis of the genetic, epigenetic, transcriptomic and miRNomic data. High resolution array comparative genomic hybridization of 56 cases of SMZL delineated a minimally deleted region (2.8 Mb) at 7q32, but showed no evidence of any cryptic homozygous deletion or recurrent breakpoint in this region. Integrated transcriptomic analysis confirmed significant under-expression of a number of genes in this region in cases of SMZL with deletion, several of which showed hypermethylation. In addition, a cluster of 8 miRNA in this region showed under-expression in cases with the deletion, and three (miR-182/96/183) were also significantly under-expressed (P<0.05) in SMZL relative to other lymphomas. Genomic sequencing of these miRNA and IRF5, a strong candidate gene, did not show any evidence of somatic mutation in SMZL. These observations provide valuable guidance for further characterisation of 7q deletion.

[1]  Guidel Ines,et al.  Expression profiling — best practices for data generation and interpretation in clinical trials , 2004, Nature Reviews Genetics.

[2]  Fei Li,et al.  Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. , 2010, Biochemical and biophysical research communications.

[3]  N. Varol,et al.  The realm of microRNAs in cancers , 2011, Molecular Biology Reports.

[4]  J. Cheville,et al.  Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer , 2009, Cancer investigation.

[5]  J. Delabie,et al.  Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. , 2004, The Journal of molecular diagnostics : JMD.

[6]  M. Mateo,et al.  MicroRNA losses in the frequently deleted region of 7q in SMZL , 2007, Leukemia.

[7]  P. Isaacson,et al.  Clonality analysis of defined B‐cell populations in archival tissue sections using microdissection and the polymerase chain reaction , 1994, Histopathology.

[8]  Geoffrey Hom,et al.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus , 2007, Proceedings of the National Academy of Sciences.

[9]  D. Catovsky,et al.  Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes , 2003, Genes, chromosomes & cancer.

[10]  L. de Leval,et al.  Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis , 2010, The Journal of pathology.

[11]  Crispin J. Miller,et al.  Cell Culture , 2010, Cell.

[12]  E. Campo,et al.  Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. , 2005, Blood.

[13]  M. Gratacós,et al.  Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. , 2010, Human molecular genetics.

[14]  J. Herman,et al.  Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer , 2011, Clinical Cancer Research.

[15]  J. Epplen,et al.  A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener’s granulomatosis , 2010, Journal of Molecular Medicine.

[16]  M. Piris,et al.  7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. , 1999, The American journal of pathology.

[17]  M Paulli,et al.  Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection , 2012, Leukemia.

[18]  Claudio G. Rolli,et al.  MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma , 2012, Acta Neuropathologica.

[19]  André Kajdacsy-Balla,et al.  miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells* , 2011, The Journal of Biological Chemistry.

[20]  K. Honda,et al.  Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression , 2007, Proceedings of the National Academy of Sciences.

[21]  Jun Liu,et al.  microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. , 2011, International journal of molecular medicine.

[22]  G. Salles,et al.  MicroRNA expression profile in splenic marginal zone lymphoma , 2012, British journal of haematology.

[23]  K. Basso,et al.  Identification of the human mature B cell miRNome. , 2009, Immunity.

[24]  Philippe Hupé,et al.  SMETHILLIUM: spatial normalization METHod for ILLumina InfinIUM HumanMethylation BeadChip , 2011, Bioinform..

[25]  K. Maclennan,et al.  Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism , 2010, Leukemia.

[26]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[27]  I. Lossos,et al.  Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities , 2012, Modern Pathology.

[28]  M. Gorospe,et al.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. , 2011, Molecular cell.

[29]  T. Ushijima,et al.  Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines. , 2006, Cancer letters.

[30]  R. Warnke,et al.  Splenic B‐Cell Marginal Zone Lymphoma , 2011 .

[31]  P. Gaulard,et al.  Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. , 2004, Blood.

[32]  H. Lee,et al.  Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. , 2009, Oncology reports.

[33]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.